Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others

IPC News

Displaying 1 to 10 of 33 Posts . Displaying 10 of Posts . Page of 4 . Go To Page: . Per Page: . . . View All Sort By: .

Announcing IPC's Newest Corporate Partner: Ortho Dermatologics

Announcing IPC's Newest Corporate Partner: Ortho Dermatologics IPC would like to thank our newest Corporate Partner, Ortho Dermatologics. Ortho Dermatologics is one of the largest prescription dermatology businesses dedicated to helping patients in the treatment of a range of therapeutic areas, including psoriasis, actinic keratosis, acne, atopic dermatitis and other dermatoses. The Ortho Dermatologics portfolio includes several leading acne, anti-fungal and corticosteroid responsive...

Read More

Get Connected: World Psoriasis Day 2019

Get Connected: World Psoriasis Day 2019 The International Psoriasis Council (IPC) strives to deepen the understanding of psoriasis and its management by leading advancements in care by facilitating cutting-edge research, convening partners to collaborate and advocate for improved treatment, and growing capacity for psoriasis management by sharing our knowledge. IPC dreams of a world free of psoriasis. We believe that psoriasis patients, no matter where they live in the world, no matter...

Read More

In Memory of Gladys León Dorantes

   Gladys Leon Dorantes with her IPC colleagues participating in a meeting of the IPC Latin America Working Group this past May at RADLA in Buenos Aires, Argentina Argentina Gladys León Dorantes  was a well-known dermatologist and psoriasis expert working in Mexico City, Mexico since 1994. She was a founding member and long-serving president of the Asociación...

Read More

Re-Categorization of Psoriasis Severity: Delphi Consensus from the International Psoriasis Council

Psoriasis severity categories have been important tools for clinicians to use in treatment decisions as well as to determine eligibility criteria for clinical studies. However, due to the heterogeneity of severity classifications and their lack of consideration for the impact of psoriasis involvement of special areas or past treatment history, patients may be mis-categorized, which can lead to under-treatment of psoriasis.

Read More

Updated Disease Classification System Adopted by the World Health Organization

On 25 May 2019, the World Health Assembly officially adopted the eleventh revision of the International Classification of Diseases (ICD-11). The ICD-11 will come into effect on 1 January 2022.

Read More

Now Available: IPC 2019 Biosimilars Education Initiative

Stay up to date on biosimilars in psoriasis and provide the best care for your patients.

Read More

IPC's July 2019 Psoriasis Review newsletter is now available!

Just published - IPC's latest issue of the Psoriasis Review newsletter featuring the Top 5, symposia reports, and more! The IPC Psoriasis Review newsletter provides practicing physicians with an authoritative research review that targets a range of key psoriasis publications most relevant to current clinical practice. The newsletter leverages the collective research and clinical expertise of IPC’s Councilors to identify the most important publications in psoriasis from the past year and provide a concise editorial commentary on the value of these publications.

Read More

Feasibility and Utility of the Psoriasis Symptom Inventory (PSI) in Clinical Care Settings: A Study from the International Psoriasis Council

Strober B, van de Kerkhof PCM, Callis Duffin K, Poulin Y, Warren RB, de la Cruz C, van der Walt JM, Stolshek BS, Martin ML, de Carvalho AVE Am J Clin Dermatol. 2019 Jun 21. doi: 10.1007/s40257-019-00458-2. [Epub ahead of print] SUMMARY Patient-reported outcome measures are important tools for capturing the patient experience and enhancing the patient-physician interaction. The Psoriasis Symptom Inventory (PSI) is a validated, 8-item instrument that assesses the severity of...

Read More

Review of international psoriasis guidelines for the treatment of psoriasis: recommendations for topical corticosteroid treatments

Corticosteroid therapy is regarded as first-line therapy for treating mild psoriasis and recalcitrant lesions. Members of the IPC Topical Therapies Working Group reviewed available international topical corticosteroids guidelines in order to understand current information and to identify areas that would benefit from greater practical guidance for dermatologists.

Read More

IPC & IEC Joint Publication "Psoriasis and Atopic Dermatitis: Similiarities and Differences" - Now Available

A joint publication of the International Psoriasis Council & International Eczema Council "Psoriasis and Atopic Dermatitis: Similiarities and Differences" is Now Available on-line

Read More
UPCOMING EVENT

The mechanistic model(s) of psoriasis: Autoimmune and/or inflammatory?

Wednesday, September 18, 2019
2:00 pm - 6:00 pm
Bordeaux, france
Register Now

Stay informed

Join the email list to receive the latest information on psoriasis meetings, manuscripts and research.
SUBSCRIBE

This website uses cookies. Please ensure your cookies are enabled. 
OK